NORTHERN TRUST CORP - STEMLINE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$3,076,000
-54.6%
635,591
-0.2%
0.00%
-50.0%
Q4 2019$6,772,000
+3.0%
637,089
+0.9%
0.00%0.0%
Q3 2019$6,576,000
-18.0%
631,670
+20.7%
0.00%0.0%
Q2 2019$8,017,000
+21.3%
523,341
+1.8%
0.00%0.0%
Q1 2019$6,608,000
+76.4%
514,229
+30.3%
0.00%
+100.0%
Q4 2018$3,747,000
-43.3%
394,502
-0.8%
0.00%
-50.0%
Q3 2018$6,605,000
+8.2%
397,848
+4.6%
0.00%0.0%
Q2 2018$6,106,000
+18.0%
380,378
+12.5%
0.00%
+100.0%
Q1 2018$5,173,000
+12.2%
338,116
+14.4%
0.00%0.0%
Q4 2017$4,611,000
+45.2%
295,579
+3.3%
0.00%0.0%
Q3 2017$3,176,000
+25.6%
286,147
+4.1%
0.00%0.0%
Q2 2017$2,529,000
+27.0%
274,824
+18.0%
0.00%0.0%
Q1 2017$1,992,000
-8.7%
232,926
+14.3%
0.00%0.0%
Q4 2016$2,181,000
+7.5%
203,831
+8.8%
0.00%0.0%
Q3 2016$2,029,000
+66.3%
187,393
+4.0%
0.00%
Q2 2016$1,220,000
+55.0%
180,113
+6.6%
0.00%
Q1 2016$787,000
-26.2%
168,938
-0.2%
0.00%
Q4 2015$1,067,000
-28.7%
169,202
-0.1%
0.00%
Q3 2015$1,496,000
-20.4%
169,391
+6.1%
0.00%
-100.0%
Q2 2015$1,880,000
-9.3%
159,718
+11.6%
0.00%0.0%
Q1 2015$2,072,000
+0.1%
143,142
+18.0%
0.00%0.0%
Q4 2014$2,069,000
+35.6%
121,314
-1.0%
0.00%
Q3 2014$1,526,000
-4.5%
122,517
+12.5%
0.00%
Q2 2014$1,598,000
-35.8%
108,946
-10.8%
0.00%
-100.0%
Q1 2014$2,488,000
-5.0%
122,163
-8.6%
0.00%0.0%
Q4 2013$2,620,000
-52.2%
133,684
+10.4%
0.00%
-50.0%
Q3 2013$5,483,000
+449.4%
121,051
+189.2%
0.00%
Q2 2013$998,00041,8570.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 475,200$6,877,0003.03%
Avoro Capital Advisors LLC 475,000$6,873,0002.64%
VHCP Management, LLC 451,400$6,532,0001.50%
Sio Capital Management, LLC 140,000$2,026,0001.15%
Opus Point Partners Management, LLC 75,000$1,085,0000.91%
Eventide Asset Management 620,200$8,974,0000.68%
Telemetry Investments, L.L.C. 55,000$796,0000.44%
Healthcare Value Capital, LLC 25,000$362,0000.40%
TFS CAPITAL LLC 259,916$3,761,0000.37%
FARALLON CAPITAL MANAGEMENT LLC 672,562$9,732,0000.14%
View complete list of STEMLINE THERAPEUTICS INC shareholders